Compare AdaptHealth Corp (AHCO) vs Huntington Ingalls Industries Inc (HII) Price & Performance

AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.

The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.

HII trades at $294.10, up 0.89% with a bullish technical signal supported by recent contract wins and strong earnings beats. The company maintains solid fundamentals with a 4.71% net margin and 12.2% ROE, while analyst consensus targets $384.50 representing 31% upside potential. Recent developments include a $418 million Navy contract and expansion in unmanned systems production.

HII presents a compelling investment case with consistent earnings outperformance, robust defense contracts, and attractive valuation metrics. Key risks include defense budget dependencies and execution challenges, but the company's $54 billion backlog and strategic positioning in naval shipbuilding support long-term growth prospects.